MD Start

Endoron Medical < Back

Endoron Medical is developing a catheter-based endograft stapling solution to overcome the challenges associated with the sealing and fixation of endografts used for the minimally invasive repair of abdominal aortic aneurysms.

The EndoStapling solution, designed to avoid highly invasive, high-mortality open surgery, is meant to secure an endograft's fixation and to improve sealing mechanisms. About 400,000 new patients in the U.S. and Europe are diagnosed with AAA disease every year, with 42% presenting complex anatomies.

Founded in 2019, Endoron Medical builds on an invention from Prof. Ron Karmeli (Hadassah Hospital, Jerusalem), who is co-founder and Chief Medical Officer of the Company.

Endoron is currently recruiting patients in its feasibility clinical trials.